| Full Name | Sumon Syed |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 22 Years |
| Location | 76 Veterans Ave, Bath, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437261005 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 239519 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Medical Center | Merced, CA | Hospital |
| Lourdes Hospital | Binghamton, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cogent Medical Care Pc | 7315836780 | 170 |
| Quantum Bay Area Hospitalist Medical Group Inc | 0648573378 | 72 |
| Merced Hospitalist Medical Group Inc | 5890948582 | 32 |
News Archive
The Cardiovascular Surgery Group at Osaka University succeeded in minimally invasive treatment of a patient with acute heart failure due to medical treatment-resistant cardiogenic shock by making use of Impella, a percutaneous auxiliary artificial heart, for the first time in Japan.
Curis, Inc. announced today that its licensee Debiopharm S.A. has treated the fifth patient in its ongoing Phase I clinical trial for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of the August 2009 license agreement between Curis and Debiopharm, Curis will receive a $3 million milestone payment from Debiopharm for the achievement of this development objective.
Extensive medical research shows that mothers' milk satisfies babies' nutritional needs far better than any manufactured infant formula.
Researchers from the Republic of Korea say that rescue therapy with tenofovir disoproxil fumarate alone is an appropriate option for patients with multidrug resistant chronic hepatitis B virus infection.
› Verified 7 days ago
| Entity Name | Cogent Medical Care Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1912941238 PECOS PAC ID: 7315836780 Enrollment ID: O20040312001215 |
News Archive
The Cardiovascular Surgery Group at Osaka University succeeded in minimally invasive treatment of a patient with acute heart failure due to medical treatment-resistant cardiogenic shock by making use of Impella, a percutaneous auxiliary artificial heart, for the first time in Japan.
Curis, Inc. announced today that its licensee Debiopharm S.A. has treated the fifth patient in its ongoing Phase I clinical trial for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of the August 2009 license agreement between Curis and Debiopharm, Curis will receive a $3 million milestone payment from Debiopharm for the achievement of this development objective.
Extensive medical research shows that mothers' milk satisfies babies' nutritional needs far better than any manufactured infant formula.
Researchers from the Republic of Korea say that rescue therapy with tenofovir disoproxil fumarate alone is an appropriate option for patients with multidrug resistant chronic hepatitis B virus infection.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sumon Syed, MD 3324 14th St, Long Island City, NY 11106-4624 Ph: (917) 902-6275 | Sumon Syed, MD 76 Veterans Ave, Bath, NY 14810-0810 Ph: (607) 664-6221 |
News Archive
The Cardiovascular Surgery Group at Osaka University succeeded in minimally invasive treatment of a patient with acute heart failure due to medical treatment-resistant cardiogenic shock by making use of Impella, a percutaneous auxiliary artificial heart, for the first time in Japan.
Curis, Inc. announced today that its licensee Debiopharm S.A. has treated the fifth patient in its ongoing Phase I clinical trial for small molecule heat shock protein 90 (Hsp90) inhibitor Debio 0932, formerly called CUDC-305. Under the terms of the August 2009 license agreement between Curis and Debiopharm, Curis will receive a $3 million milestone payment from Debiopharm for the achievement of this development objective.
Extensive medical research shows that mothers' milk satisfies babies' nutritional needs far better than any manufactured infant formula.
Researchers from the Republic of Korea say that rescue therapy with tenofovir disoproxil fumarate alone is an appropriate option for patients with multidrug resistant chronic hepatitis B virus infection.
› Verified 7 days ago
Tomas E Vence, MD Internal Medicine Medicare: Medicare Enrolled Practice Location: 76 Veterans Ave, Bath, NY 14810 Phone: 607-664-4000 | |
Dr. Carol L Holobinko, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7603 Route 54, Bath, NY 14810 Phone: 607-776-4166 Fax: 607-776-8032 | |
Dr. Mohammad H Mirza, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7603 Route 54, Bath, NY 14810 Phone: 607-776-4176 Fax: 607-776-8032 | |
Anselmo Deasis, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 7433 State Route 54, Bath, NY 14981 Phone: 607-776-9198 Fax: 607-776-9199 | |
Dr. Alipio F Encarnacion, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 76 Veterans Ave, Bath, NY 14810 Phone: 607-664-4000 | |
Dr. Michelle Grosso, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 76 Veterans Ave, Bath, NY 14810 Phone: 914-819-3173 |